Culleton Bruce has filed 5 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 3000000 shares of PROKIDNEY CORP. ($PROK) on March 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | PROKIDNEY CORP. | $PROK | Culleton Bruce | Chief Executive Officer | A | Employee stock option (right to buy) | 3000000 | $0.00 | 3,000,000.0000 | 159,288,931 | 9999.99% | 1.88% |
| March 1, 2025 | PROKIDNEY CORP. | $PROK | Culleton Bruce | Chief Executive Officer | A | Employee stock option (right to buy) | 1796000 | $0.00 | 1,796,000.0000 | 163,693,707 | 9999.99% | 1.10% |
| Sept. 13, 2024 | PROKIDNEY CORP. | $PROK | Culleton Bruce | Chief Executive Officer | A | Employee stock option (right to buy) | 500000 | $0.00 | 500,000.0000 | 168,297,916 | 9999.99% | 0.30% |
| Dec. 3, 2023 | PROKIDNEY CORP. | $PROK | Culleton Bruce | Chief Executive Officer | A | Employee stock option (right to buy) | 2000000 | $0.00 | 2,000,000.0000 | 171,578,320 | 9999.99% | 1.17% |
| Aug. 1, 2023 | PROKIDNEY CORP. | $PROK | Culleton Bruce | EVP, Clinical Development | A | Employee stock option (right to buy) | 485000 | $0.00 | 485,000.0000 | 171,578,320 | 9999.99% | 0.28% |